Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical and Chinese medicine. Its products include digestive system medication such as Weidimei (aluminum magnesium carbonate) and Changsong (polyethylene glycol), psychiatric nervous system medication such as Duliang soft capsules, and ear, nose, and throat (ENT) medication such as citrus ice plum tablets. The company was founded on November 4, 1996 and is headquartered in Chongqing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company